Kyinno Biotechnology, Inc. is excited to announce our participation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Oct. 22–26, 2025, at the Hynes Convention Center in Boston, MA. Visit us at Booth #200 to learn more about our latest innovations in drug discovery and therapeutic evaluation.
话题标签Kyinno‘s poster presentations include:
Poster Session B | Friday, Oct. 24, 12:30–4:00 p.m.
• BTK-EndoMut Platform: Engineered Resistance Models Accelerating BTK-Targeted Drug Discovery
Poster Session C | Saturday, Oct. 25, 12:30–4:00 p.m.
• Revealing Hidden Off-target Risks of CTLA-4: A High-Sensitivity Assessment via the MPSA-AB5000 Platform
• ADC Screening Platform: A Useful Platform for ADC Drug Evaluation
We look forward to sharing our work and connecting with the cancer research community at this premier international conference.
Learn more: https://cn.kyinno.com/
